Sign in

You're signed outSign in or to get full access.

MI

MSC INDUSTRIAL DIRECT CO INC (MSM)·Q3 2025 Earnings Summary

Executive Summary

  • Fiscal Q3 2025 landed broadly in line with internal expectations and modestly above Wall Street on revenue and normalized EPS; net sales were $971.1M (-0.8% YoY) and adjusted diluted EPS was $1.08, with sequential ADS up 7% and adjusted operating margin improving to 9.0% .
  • Against S&P Global consensus, MSM delivered a slight beat: revenue $971.1M vs $969.2M estimate and Primary EPS $1.08 vs $1.03 estimate; EBITDA $109.4M vs $106.6M estimate* (beats) .
  • Q4 FY25 outlook guides ADS YoY between -0.5% to +1.5% and adjusted operating margin 8.5%–9.0%; full-year free cash flow conversion raised to ~120% from ~100% previously (positive) .
  • Near-term stock reaction catalysts: tariff-driven pricing actions and cost pass-through forming a narrow price-cost spread, execution on sales optimization and web initiatives, and Q4 gross margin seasonality vs guidance .

*Values retrieved from S&P Global.

What Went Well and What Went Wrong

What Went Well

  • Sequential momentum: ADS improved 7% QoQ, above historical patterns, with adjusted operating margin up 190bps sequentially to 9.0% at the midpoint of outlook; CEO highlighted “early signs of progress” across core customers, high-touch solutions, and cost-to-serve .
  • High-touch solutions growth: vending ADS up ~8% YoY and implants up ~10% YoY; both each represented ~19% of total net sales, underscoring traction in solutions footprint .
  • Cash generation and capital return: Q3 free cash flow conversion ~134%, year-to-date ~129%; $56M returned in Q3 and $181M YTD via dividends and buybacks .
  • Quote: “We delivered fiscal third quarter results that were in line with our expectations… we saw early signs of progress in… reenergizing the core customer…” — CEO Erik Gershwind .

What Went Wrong

  • Margin compression YoY and higher OpEx: GAAP operating margin fell to 8.5% (from 10.9% YoY); adjusted OpEx rose ~$22M YoY, driven by personnel costs, pressuring adjusted operating margin to 9.0% (down ~240bps YoY) .
  • Macro softness and tariffs: Manufacturing end markets remained subdued with caution around tariffs; April was notably soft, followed by improvement in May/June, leaving customers hesitant on future production levels .
  • Gross margin mix headwind: Public sector strength typically creates Q4 seasonal gross margin pressure; management expects only a narrow favorable price-cost spread as costs step up into Q4 .

Financial Results

MetricFY24 Q3 (YoY Comp)FY25 Q2 (Sequential Base)FY25 Q3 (Reported)
Net Sales ($USD Millions)$979.4 $891.7 $971.1
Diluted EPS (GAAP) ($)$1.27 $0.70 $1.02
Adjusted Diluted EPS ($)$1.33 $0.72 $1.08
Gross Margin (%)40.9% 41.0% 41.0%
Operating Margin (GAAP, %)10.9% 7.0% 8.5%
Operating Margin (Adjusted, %)11.4% 7.1% 9.0%

Estimates vs Actuals (S&P Global, Q3 2025):

MetricConsensusActual
Revenue ($USD Millions)$969.2*$971.1
Primary EPS ($)$1.03*$1.08 (adjusted)
EBITDA ($USD Millions)$106.6*$109.4

*Values retrieved from S&P Global.

KPIs and Mix:

KPIFY25 Q3
ADS YoY-0.8%
ADS QoQ+7%
Core customers ADS YoY-0.8%
National accounts ADS YoY-1.7%
Public sector ADS YoY+2.4%
Vending ADS YoY~+8% (~19% of sales)
Implant sales YoY+10% (~19% of sales)
Price contribution (YoY)~+80bps

Balance Sheet (selected):

  • Net debt ≈ $449M; ~1.1x EBITDA .
  • Cash and equivalents $71.7M; total assets $2,475.6M .
  • Total debt (current + long-term) $521.0M ($236.1M current; $285.0M long-term) .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
ADS Growth (YoY)Q4 FY25N/A(-0.5)% to +1.5% New
Adjusted Operating MarginQ4 FY25N/A8.5%–9.0% New
Gross Margin AssumptionQ4 FY25N/A~40.9% ±20bps; better than typical -40bps seasonal decline New
Adjusted OpEx (seq.)Q4 FY25N/ADown ~$2–$4M QoQ New
Depreciation & AmortizationFY25~$90–$95M Lower end of ~$90–$95M Maintained/low end
Capital ExpendituresFY25~$100–$110M Lower end of ~$100–$110M Maintained/low end
Interest & Other ExpenseFY25~$45M ~$45M Maintained
Free Cash Flow Conversion (Adjusted)FY25~100% ~120% Raised
Tax RateFY25~24.5%–25.0% ~24.5%–25.0% Maintained
DividendQ3 FY25—$0.85 per share payable Jul 23, 2025 Declared

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 FY25)Previous Mentions (Q2 FY25)Current Period (Q3 FY25)Trend
Web enhancements & marketingLaunched upgrades; focus on core growth Website upgrades + enhanced marketing campaign Direct traffic up low double digits YoY; mid-single digits QoQ; improving conversion Improving
Tariffs & pricing—Late-March surgical price increase (referencing prior)Broad-based price increase in last days of Q3; low single-digit sizing; narrow price-cost in Q4 Building pressures; agile response
High-touch solutions (vending, implants)Continued expansion of solutions footprint Expansion continued Vending ADS +~8% YoY; implants +10% YoY; each ~19% of sales Strengthening
Core customer re-energizingEarly steps; room for improvement Completed coverage redesigns; seller effectiveness initiative Core ADS -0.8% YoY; best sequential performer; redesign driving higher touches Improving sequentially
Macro & end marketsDecember timing impact; near-term softness Demand at low levels; supplier rebates aided margins Manufacturing subdued; April soft amid tariff uncertainty; May/June improved; aerospace strong Mixed/Cautious
Digital core & technology leadershipPaused digital core amid web work (context)—New CIO; gearing digital core back up to drive productivity Reaccelerating
Productivity & cost-to-serveMission Critical pipeline Productivity initiatives in focus Network optimization targeting $10–$15M annualized savings by FY26 Building

Management Commentary

  • CEO on progress: “Average daily sales… declined 0.8%… slightly above the midpoint… Gross margins… navigated tariff driven inflation to produce positive price cost… adjusted operating margins of 9%… encouraging start to newly launched growth initiatives” .
  • CFO on profitability and OpEx: “Adjusted operating expenses stepped up ~$22 million year over year… primarily higher personnel-related costs… On a % of sales basis, adjusted operating expenses decreased 180 bps sequentially” .
  • COO on sales coverage: Redesigned territories across public sector, national accounts, and core; increased customer touches and improved sales per rep per day trends .
  • CFO on capital allocation: “Free cash flow conversion… ~134% in Q3 and ~129% YTD… returned ~$56M in Q3 and ~$181M YTD” .
  • CEO on macro: “Most… end markets remain soft… Aerospace remains a bright spot… April soft beyond Easter timing… followed by improving trends in May and continued into June” .

Q&A Highlights

  • Pricing trajectory and tariffs: Management implemented a broad-based, low-single-digit price increase late in Q3, with partial realization in Q4 due to contracted holding periods; willingness to move again as needed given fluid supplier inflation .
  • Q4 margins: Gross margin targeted ~40.9% ±20bps (better than typical -40bps sequential seasonality); expect narrow favorable price-cost spread with costs stepping up .
  • FY26 framing: Aim to resume more normalized incremental margin dynamics (20%+ over a cycle) as mix, pricing, and productivity initiatives moderate OpEx growth; more detail next quarter .
  • Core and web marketing: Marketing “in full swing,” with web pricing realignment acting as an enabler; goal to have core grow consistent with company average and eventually exceed IP by 400bps or more .
  • Other modeling notes: Acquisition contribution (~60bps) lapped by Q4; unusual other expense benefit from peso revaluation; no change to annual interest/other guidance .

Estimates Context

  • Q3 FY25 performance vs S&P Global consensus: Revenue $971.1M vs $969.2M estimate (beat); Primary EPS $1.08 vs $1.03 estimate (beat); EBITDA $109.4M vs $106.6M estimate (beat)* .
  • Sequential trajectory: ADS +7% QoQ, adjusted operating margin up ~190bps QoQ supports modest upward estimate revisions on normalized EPS if pricing holds and costs are contained .
  • Forward context: Q4 FY25 consensus exists; management’s outlook implies flattish revenue and adjusted margin 8.5%–9.0%, with gross margin seasonality better than normal; near-term estimate changes likely hinge on tariff evolution and mix .

*Values retrieved from S&P Global.

Key Takeaways for Investors

  • Quarter was operationally solid with sequential improvements; normalized EPS and revenue slightly beat consensus while GAAP EPS reflected higher OpEx and one-time items .
  • Pricing actions and tariff management create a narrow but positive price-cost spread into Q4; watch for supplier cost creep and contracted customer price realization lag .
  • High-touch solutions (vending/implants) are gaining share and underpin mix-resilient growth; continued expansion should support medium-term margins and wallet share .
  • Raised FY25 free cash flow conversion to ~120% and consistent capital returns (dividends/buybacks) bolster defensive attributes amid macro caution .
  • Execution on sales coverage redesign, web enhancements, and digital core reacceleration are key to reenergizing core customers and lifting ADS above IP by 400bps long-term .
  • Near-term trading lens: Monitor monthly ADS trends around tariff deadlines, Q4 gross margin vs guidance, and any incremental pricing moves; Public sector mix could pressure GM seasonality despite guidance .
  • Medium-term thesis: As macro stabilizes and self-help matures, incremental margins can normalize toward 20%+ with OpEx moderation and productivity savings ($10–$15M annualized run rate by FY26) .